Reflecting the growing impact of Artificial Intelligence on the pharmaceutical sector, Issue 1/2020 of EPLR features articles on AI as a medical device, the patentability of AI generated drugs and the EU – US Privacy Shield Regime.
In addition to the articles this issue features reports on medicine shortages and the effectiveness of therapeutic and biosimilar pharmaceutical competition. Concluding the issue we have a Case Note on Case T-733/17 GMPO which addressed problems with the orphan designation procedure.
View the whole table of content of EPLR 1/2020: Here
The European Pharmaceutical Law Review (EPLR) is seeking original research papers for a special issue on global pharmaceutical law and policy.
Please see for details our Special Call for Papers